Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Strains from Gold Miners in South Africa

被引:40
作者
Dorman, Susan E. [1 ]
Chihota, Violet N. [2 ]
Lewis, James J. [2 ,3 ]
van der Meulen, Minty [2 ]
Mathema, Barun [4 ]
Beylis, Natalie [5 ]
Fielding, Katherine L. [3 ]
Grant, Alison D. [3 ]
Churchyard, Gavin J. [2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Publ Hlth Res Inst, TB Ctr, Newark, NJ USA
[5] Natl Hlth Lab Serv, Braamfontein, South Africa
基金
美国国家卫生研究院;
关键词
BACTEC MGIT 960; CLINICAL SPECIMENS; LOWENSTEIN-JENSEN; CULTURE; ASSAY; RIFAMPIN; DIAGNOSIS; RECOVERY; SYSTEM; IMPACT;
D O I
10.1128/JCM.05723-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
GenoType MTBDRplus is a molecular assay for detection of Mycobacterium tuberculosis and drug resistance. Assay performance as applied directly to consecutive unselected sputum samples has not been established. The objective of this study was to determine the accuracy of the MTBDRplus test for direct detection of M. tuberculosis (in sputum) and for drug resistance in consecutively submitted sputum samples. In this cross-sectional study in South Africa, one sputum specimen from each person suspected of having pulmonary tuberculosis was tested by smear microscopy, direct MTBDRplus, and Mycobacterial Growth Indicator Tube (MGIT) culture with MGIT drug susceptibility testing. MGIT results were the reference standard. We tested 2,510 sputum samples, and 529 (21.1%) were positive for M. tuberculosis by MGIT. Direct MTBDRplus identified M. tuberculosis in 256 of 529 specimens (sensitivity, 48.4%; 95% confidence interval [CI], 44.1, 52.7). The sensitivity of MTBDRplus for M. tuberculosis detection by sputum smear status was as follows: smear negative, 13.7% (95% CI, 9.8, 18.4); smear scanty, 46.2% (95% CI, 19.2, 74.9); smear 1+, 69.1% (95% CI, 55.2, 80.9); smear 2+, 86.3% (95% CI, 73.7, 94.3); smear 3+, 89.8% (95% CI, 83.7, 94.2). Direct MTBDRplus testing was negative for 1,594/1,612 sputum samples that were culture negative for M. tuberculosis (specificity, 98.9%; 95% CI, 98.2, 99.3). For specimens positive for M. tuberculosis by MTBDRplus, this assay's sensitivity and specificity for rifampin resistance were 85.7% (95% CI, 57.2, 98.2) and 96.6% (95% CI, 93.2, 98.6) and for isoniazid resistance they were 62.1% (95% CI, 42.3, 79.3) and 97.9% (95% CI, 94.8, 99.4). For sputum testing, the sensitivity of MTBDRplus is directly related to the specimen's bacillary burden. Our results support recommendations that the MTBDRplus test not be used for direct testing of smear-negative or paucibacillary sputum samples.
引用
收藏
页码:1189 / 1194
页数:6
相关论文
共 33 条
[1]   Validation of the GenoType® MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand [J].
Anek-vorapong, Rapeepun ;
Sinthuwattanawibool, Chalinthorn ;
Podewils, Laura Jean ;
McCarthy, Kimberly ;
Ngamlert, Keerataya ;
Promsarin, Busakorn ;
Varma, Jay K. .
BMC INFECTIOUS DISEASES, 2010, 10
[2]  
[Anonymous], 2008, POL STAT MOL LIN PRO
[3]   Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens [J].
Bang, Didi ;
Andersen, Ase Bengard ;
Thomsen, Vibeke Ostergaard .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (07) :2605-2608
[4]   Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa [J].
Barnard, Marinus ;
Allbert, Heidi ;
Coetzee, Gerrit ;
O'Brien, Richard ;
Bosiman, Marlein E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (07) :787-792
[5]   Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [J].
Boehme, Catharina C. ;
Nabeta, Pamela ;
Hillemann, Doris ;
Nicol, Mark P. ;
Shenai, Shubhada ;
Krapp, Fiorella ;
Allen, Jenny ;
Tahirli, Rasim ;
Blakemore, Robert ;
Rustomjee, Roxana ;
Milovic, Ana ;
Jones, Martin ;
O'Brien, Sean M. ;
Persing, David H. ;
Ruesch-Gerdes, Sabine ;
Gotuzzo, Eduardo ;
Rodrigues, Camilla ;
Alland, David ;
Perkins, Mark D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11) :1005-1015
[6]  
Bwanga F, 2010, INT J TUBERC LUNG D, V14, P890
[7]   Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa [J].
Calver, Alistair D. ;
Falmer, Alecia A. ;
Murray, Megan ;
Strauss, Odelia J. ;
Streicher, Elizabeth M. ;
Hanekom, Madelene ;
Liversage, Thelma ;
Masibi, Mothusi ;
van Helden, Paul D. ;
Warren, Robin M. ;
Victor, Thomas C. .
EMERGING INFECTIOUS DISEASES, 2010, 16 (02) :264-271
[8]  
Chien HP, 2000, INT J TUBERC LUNG D, V4, P866
[9]  
Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024
[10]   Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening [J].
Churchyard, Gavin J. ;
Fielding, Katherine L. ;
Lewis, James J. ;
Chihota, Violet N. ;
Hanifa, Yasmeen ;
Grant, Alison D. .
AIDS, 2010, 24 :S19-S27